IPO registrations (S-1, F-1) · Registrants

EQRx, Inc.

SEC CIK
1843762 · filings on EDGAR ↗
Former names
CM Life Sciences III Inc. (2021–2021)
Registration
Form S-1, first filed 2021-02-25, last 2021-12-21; 2 initial registrations, 1 amendment
Outcome
Final prospectus filed 2021-04-08; declared effective 2021-04-06
Industry (SIC)
Pharmaceutical Preparations 2834
Business address
50 HAMPSHIRE STREET, Cambridge, MA 02139
EIN
86-1691173
EDGAR entity type
operating
Insiders and CEO pay
EQRx, Inc. on the corporate pages

Offering terms

Final price
$10.00 per share (424B4 filed 2021-04-08, an initial public offering)
Shares sold
48,000,000
Gross proceeds
$480,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol CMLT
Lead underwriters
Jefferies; Cowen

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 14

FiledFormWhat it isName as filedEDGAR
2021-02-25S-1S-1 (registration)CM Life Sciences III Inc.0001213900-21-011439 ↗
2021-03-25S-1/AS-1/A (amendment)CM Life Sciences III Inc.0001213900-21-017805 ↗
2021-04-06S-1MEFS-1MEF (added securities)CM Life Sciences III Inc.0001213900-21-020491 ↗
2021-04-06EFFECTEFFECT (declared effective)CM Life Sciences III Inc.9999999995-21-001298 ↗
2021-04-08424B4424B4 (final prospectus)CM Life Sciences III Inc.0001213900-21-020818 ↗
2021-12-01EFFECTEFFECT (declared effective)CM Life Sciences III Inc.9999999995-21-004524 ↗
2021-12-21S-1S-1 (registration)EQRx, Inc.0001213900-21-066498 ↗
2021-12-23EFFECTEFFECT (declared effective)EQRx, Inc.9999999995-21-004818 ↗
2022-03-28EFFECTEFFECT (declared effective)EQRx, Inc.9999999995-22-000733 ↗
2023-03-03EFFECTEFFECT (declared effective)EQRx, Inc.9999999995-23-000514 ↗
2023-03-03EFFECTEFFECT (declared effective)EQRx, Inc.9999999995-23-000515 ↗
2023-11-17EFFECTEFFECT (declared effective)EQRx, Inc.9999999995-23-003369 ↗
2023-11-17EFFECTEFFECT (declared effective)EQRx, Inc.9999999995-23-003373 ↗
2023-11-17EFFECTEFFECT (declared effective)EQRx, Inc.9999999995-23-003374 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2021-03-25S-1/Aregistration statement$10.0040,000,000$400,000,000Nasdaq CMLT2primary document; price sentence, shares headline, proceeds table, cover names 2document ↗
2021-04-08424B4final prospectus$10.0048,000,000$480,000,000Nasdaq CMLT2primary document; price sentence, shares headline, proceeds table, cover names 2document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Casdin EliDirector; Director,Officer,TenPercentOwner; Director,TenPercentOwner; TenPercentOwnerChief Executive Officer; Officer (CEO)72021–2023
C-LSH III LLCDirector,TenPercentOwner; TenPercentOwner22021
CMLS Holdings III LLCDirector,TenPercentOwner; TenPercentOwner22021
Emes BrianOfficerCFO and Secretary12021
HENRY CHRISTIAN ODirector12021
Meister Keith A.Director,TenPercentOwner22021
M-LSH III LLCDirector,TenPercentOwner; TenPercentOwner22021
Owusu-Kesse KwameDirector12021
ROBINS CHAD MDirector12021
ROBINS HARLAN SDirector12021
Rodriguez ShaunOfficerChief Strategy Officer12021
Abernethy AmyDirector72021–2023
BERNS PAUL LDirector52021–2023
Borisy AlexisDirector; Director,OfficerExecutive Chairman42021–2023
GIUSTI KATHRYN EDirector52021–2023
Hedrick EricOfficerChief Physician Executive42021–2023
Horning SandraDirector52021–2023
MEANWELL CLIVEDirector52021–2023
MERKSAMER SAMUEL J.Director32021–2023
Nallicheri MelanieDirector,OfficerChief Executive Officer52021–2023
Rubin JamiOfficerChief Financial Officer42021–2023
Yeshwant KrishnaDirector32021–2023
Conde JorgeDirector42021–2023
AH Bio Fund II-B, L.P.TenPercentOwner32021–2023
AH Bio Fund III-B, L.P.TenPercentOwner32021–2023
AH Bio Fund III, L.P.TenPercentOwner32021–2023
AH Bio Fund III-Q, L.P.TenPercentOwner32021–2023
AH Bio Fund II, L.P.TenPercentOwner32021–2023
AH Equity Partners Bio III, L.L.C.TenPercentOwner32021–2023
AH Equity Partners Bio II, L.L.C.TenPercentOwner32021–2023
AH Equity Partners LSV II, L.L.C.TenPercentOwner32021–2023
AH Equity Partners LSV I, L.L.C.TenPercentOwner32021–2023
Andreessen Horowitz LSV Fund I-B, L.P.TenPercentOwner32021–2023
Andreessen Horowitz LSV Fund II-B, L.P.TenPercentOwner32021–2023
Andreessen Horowitz LSV Fund II, L.P.TenPercentOwner32021–2023
Andreessen Horowitz LSV Fund II-Q, L.P.TenPercentOwner32021–2023
Andreessen Horowitz LSV Fund I, L.P.TenPercentOwner32021–2023
Andreessen Horowitz LSV Fund I-Q, L.P.TenPercentOwner32021–2023
Andreessen Marc LTenPercentOwner32021–2023person page Fuzzy
HOROWITZ BENJAMIN ATenPercentOwner32021–2023
Ciarimboli DinaOfficerGeneral Counsel and Secretary52022–2023

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
SEC filerEQRx, Inc.SEC filers (EDGAR)CIK (EXACT)
Person pageMarc L AndreessenPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, MA first:

More with this interest.

In other datasets, the same topic (Health) in MA:

Interests: Pharmaceutical Preparations · Health